Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995, Heart Br Card Soc, vol.84, pp.25-30, 2000. ,
Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study, Heart Br Card Soc, vol.83, pp.525-555, 2000. ,
Cerebrovascular accidents in infective endocarditis: role of anticoagulation, Eur Heart J, vol.11, pp.1074-1082, 1990. ,
Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland, Arch Intern Med, vol.160, pp.2781-2788, 2000. ,
Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study, Circulation, vol.112, pp.69-75, 2005. ,
Changing profile of infective endocarditis: results of a 1-year survey in France, JAMA, vol.288, pp.75-81, 2002. ,
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS), Am Heart J, vol.154, pp.1086-94, 2007. ,
Echocardiography predicts embolic events in infective endocarditis, J Am Coll Cardiol, vol.37, pp.1069-76, 2001. ,
Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications, J Am Coll Cardiol, vol.18, pp.1191-1200, 1991. ,
Candida albicans endocarditis: ultrastructural studies of vegetation formation, Infect Immun, vol.20, pp.279-89, 1978. ,
Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains, Infect Immun, vol.63, pp.3634-3675, 1995. ,
Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects, Circulation, vol.99, pp.2791-2798, 1999. ,
Toward reducing embolic complications from endocarditis, J Am Coll Cardiol, vol.42, pp.781-784, 2003. ,
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus, J Clin Invest, vol.112, pp.222-255, 2003. ,
Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, Int J Antimicrob Agents, vol.11, pp.159-61, 1999. ,
Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis, J Intern Med, vol.231, pp.543-549, 1992. ,
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis, J Am Coll Cardiol, vol.42, pp.775-80, 2003. ,
Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.44, pp.1180-1186, 2007. ,
Chronic antiplatelet therapy and mortality among patients with infective endocarditis, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.15, pp.193-202, 2009. ,
Effect of long-term aspirin use on embolic events in infective endocarditis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.46, pp.37-41, 2008. ,
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid, J Infect, vol.58, pp.332-340, 2009. ,
Modifiers of symptomatic embolic risk in infective endocarditis, Mayo Clin Proc, vol.86, pp.1068-74, 2011. ,
The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left-sided infective endocarditis, Scand J Infect Dis, vol.43, pp.899-904, 2011. ,
Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study), Am J Cardiol, vol.97, pp.1332-1338, 2006. ,
Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury, Thromb Haemost, vol.93, pp.145-52, 2005. ,
Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease, Clin Lab, vol.48, pp.287-96, 2002. ,
Anti-inflammatory effects of statins: clinical evidence and basic mechanisms, Nat Rev Drug Discov, vol.4, pp.977-87, 2005. ,
Statins for the prevention and treatment of infections: a systematic review and meta-analysis, Arch Intern Med, vol.169, pp.1658-67, 2009. ,
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.30, pp.633-641, 2000. ,
Experience from a multicentre stroke register: a preliminary report, Bull World Health Organ, vol.54, pp.541-53, 1976. ,
Bias reduction of maximum likelihood estimates, Biometrika, vol.82, pp.667-667, 1995. ,
A solution to the problem of separation in logistic regression, Stat Med, vol.21, pp.2409-2428, 2002. ,
The use of nonsteroidal antiinflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers, J Infect Dis, vol.166, pp.861-866, 1992. ,
Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin, Antimicrob Agents Chemother, vol.45, pp.3262-3268, 2001. ,
Salicylic acid: an old dog, new tricks, and staphylococcal disease, J Clin Invest, vol.112, pp.149-51, 2003. ,
Effect of sulphinpyrazone on the development of experimental endocardial vegetations, Cardiovasc Res, vol.16, pp.657-62, 1982. ,
Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis, Antimicrob Agents Chemother, vol.39, pp.1748-51, 1995. ,
Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin, Circulation, vol.106, pp.2104-2114, 2002. ,
Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, vol.91, pp.3527-61, 1998. ,
Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase, J Biol Chem, vol.273, pp.24266-71, 1998. ,
A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke, N Engl J Med, vol.325, pp.1261-1267, 1991. ,
Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke, Drugs, vol.65, pp.461-71, 2005. ,